PARP1 and cancer: Such induced lethality is not observed in XRCC4 single knockout cells or XRCC4/PARP1 doubly deficient cells, leading us to hypothesize that Pol θ might represent a promising target for killing NHEJ-deficient cancer cells exposed to G1 DNA damage.